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Abstract 
Previous studies have shown that broccoli bioactives may have anti-cancer activity.  In 
this work, we hypothesized that broccoli bioactive components inhibit invasion of human 
prostate cancer cell line, DU145, in an in vitro model system. DU145 cells were plated into 
Matrigel invasion chambers placed in 24-well plates with complete growth medium as a chemo-
attractant. In the chambers, cells were treated with sulforaphane (SF), indole-3-carbinol (I3C), 
hydrolyzed neoglucobrassicin (hNGB), and quercetin (Q) individually or in selected combinations. 
After a total of 48 hour treatment exposure, with the treatments being renewed at the 24th hour, 
the invading cells were fixed, stained, and counted. The results of Matrigel invasion assay 
indicate that the invasive ability of DU145 cells was significantly inhibited by the physiologically 
relevant levels of SF (3-5 µM) and I3C (120-200 nM), but not NGB (1-50 µM) or Q (1-5 µM). We 
further performed the MTT assay to examine whether the reduction of invading cells were 
attributed to the decreased invasive ability or cell death in the condition of the Matrigel invasion 
assay. DU145 cells were plated in 96-well plates and followed the treatment and incubation 
procedure similar to the Matrigel invasion assay, with invasion-suppressive concentrations of SF 
(3-5 µM) or I3C (160 and 200 nM). At the end of 48 hours, MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 
diphenyl tetrazolium bromide) was added to each well, followed by incubation for 4-6 hours. The 
96-well plates were analyzed at the absorbance of 540nm. The result of MTT assay shows that 
invasion-suppressive concentrations of SF and I3C did not decrease cell viability, meaning that SF 
and I3C inhibited DU145 cells not by causing cell death but by other regulatory pathways that 
may suppress invasion. The results of this study provide the support for broccoli consumption by 
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prostate cancer patients. Further work will be needed to evaluate whether broccoli bioactives 
reduce metastasis of prostate cancer to extra-prostatic sites. 
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Chapter I 
Literature Review 
Introduction  
In 2014, prostate cancer is estimated to be the leading type of cancer diagnosed and the   
second leading cause of cancer-related deaths in men in the United States (Siegel et al., 2014). 
According to the five-year survival rate study (between 2002-2008) based on the stage at 
diagnosis, 100% of the patients diagnosed with the localized or regional prostate cancer 
survived; however, only 28% of the patients with metastasized prostate cancer survived at the 
end of the five years (Siegel et al., 2014). In other words, metastatic disease is the main cause of 
death for prostate cancer. Unfortunately, it has been reported that one out of seven prostate 
cancer patients would develop metastatic prostate cancer (Siegel et al., 2014). Therefore, it is 
important to decrease the incidence of metastasis, in order to increase the survival rate in men 
with prostate cancer. 
 
Risk Factors of Prostate Cancer 
Age 
The incidence of prostate cancer is age-related. Men aged less than 40 years are rarely 
diagnosed with prostate cancer; while those aged around 70 years are commonly diagnosed with 
prostate cancer (Bostwick et al., 2004). Therefore, the American Cancer Society recommends 
that men should have prostate cancer screening at the age starting at 50 (“American Cancer 
Society Guidelines for the Early Detection of Cancer,” 2013). 
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Race 
Race plays an important role in both incidence and mortality rate of prostate cancer. Siegel 
and colleagues (2014) reported that African American men have higher incidence and mortality 
rate of prostate cancer than non-Hispanic white, Asian American, and Pacific islanders in the 
United States. Since all the cases in this analysis were investigated in the United States during 
2006-2010, the differences between races should not be due to the geographic impact, but due, 
at least in part, to ethnicity. Therefore, race could impact the incidence and mortality rate of 
prostate cancer (Siegel et al., 2014). 
 
Region of Residency 
 Environmental factors vary in different regions of residency, where the interactions of 
climate, life style, culture, health care system, and others could have influence on the incidence 
and mortality rate of prostate cancer. Based on a continental statistics, men in North America 
are more likely to have prostate cancer; whereas those in Asia have a 25.5-time lower incidence 
rate than in North America. As for the mortality rate, on the other hand, Oceania has the highest 
death rate, and Asia has the lowest death rate of prostate cancer (Kamangar, 2006).  
 Sun exposure―another factor related to the latitude of residency―could decrease 
prostate cancer risk and mortality rate. The John group (2007) suggested that the prostate 
cancer risk was inversely related to sun exposure (John et al., 2007). Similarly, the Hanchette 
group (1992) found that the increase in the mortality rate of prostate cancer was correlated to 
the decrease in the UV exposure (Hanchette & Schwartz, 1992). Since sun exposure also directly 
affects Vitamin D formation in the human body, both groups related that prostate cancer risk 
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and mortality rate could be altered by vitamin D formation stimulated by sun exposure. In 
conclusion, region of residency may change the risk of prostate cancer, and sunlight―a trigger of 
vitamin D production―has been considered to be one of important environmental factors.  
 
Family History 
Family history is believed to be one of the primary risk factors of prostate cancer. Frank 
(2014) introduced the population attributable fraction (PAF)―the ratio of a certain disease that 
could be prevented if freed from the specific risk factor―to examine the influence of familial 
factors on prostate cancer. He suggested that prostate cancer has the highest PAF of 13.9% in 
comparison with other types of cancer, such as breast (7.46%), and colorectum (6.78%), based 
on the database of 8,148,737 individuals in Swedish Family-Cancer center. Hence, family history 
may be an indicator of prostate cancer incidence (Frank et al., 2014). 
 
Diet 
 Different dietary patterns influence health outcomes, including the incidence of prostate 
cancer. Micronutrients, bioactives, or carcinogens in the diet have been thought to be important 
factors that affect prostate cancer occurrence. Indeed, epidemiological studies have found that 
high consumption of animal fat and red meat is related to increased risk of prostate cancer 
(Kolonel, 2001), whereas high consumption of fruit and vegetable is related to reduced risk of 
prostate cancer (reviewed in Nelson et al., 2014; Giovannucci et al., 2003). Thence, diet may 
alter the risk of prostate cancer occurrence. 
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Metastasis  
 Metastasis is a group of sequential events that result in the spread of cancer cells from 
the primary organ to distant parts of the body. This process (figure 1.1) begins with epithelial-
mesenchymal transition (EMT) and invasion of extracellular matrix (or basement membrane in 
figure 1.1), followed by the escape of cancer cells into the circulation system, and finally ends 
with the extravasation of the tumor cells into the metastatic sites where the metastatic cells 
undergo mesenchymal-epithelial transition (MET) and re-colonization (Arya et al., 2006). 
 
Epithelial-Mesenchymal Transition 
 Epithelial-mesenchymal transition, or EMT, is an essential initiation process before tumor 
cell invasion. Tumor cells undergo the morphological changes from epithelial phenotype to 
mesenchymal phenotype, where they lose cell-to-cell adhesion, and gain mobility, allowing them 
to become free from the original sites. The cell-cell adhesion is mediated by classes of cell 
adhesion molecules, or CAMs. The most well-observed CAMs in cancer studies are E-cadherin 
and N-cadherin, calcium-dependent cadherins (reviewed in Hanahan & Weinberg, 2000; Arya et 
al., 2006). The loss of E-cadherin expression and the increase in N-cadherin expression are 
believed to be the hallmarks of EMT. The Tomita group (2000) showed that lowered E-cadherin 
and increased N-cadherin expression was found in undifferentiated prostate tumors and in 
metastases from the prostate tissues obtained by radical prostatectomy or transurethral 
resection. They also found that normal prostate tissue obtained from cystoprostatectomy did 
not express N-cadherin; whereas high-grade prostate cancer and prostate cancer metastases 
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were reported to have increased N-cadherin level (Tomita et al., 2000). Collectively, the results 
indicated that decreased expression of E-cadherin with increased expression of N-cadherin is a 
sign of prostate cancer progression. Besides, the Gravdal group (2007) also examined the 
prostate tissue from 104 men treated by radical prostatectomy during 1988-1994. They 
suggested that low E-cadherin expression is significantly associated with seminal vesicle invasion, 
clinical recurrence, skeletal metastasis, and cancer-specific death; and high expression of N-
cadherin is related to seminal vesicle invasion, clinical recurrence, and skeletal metastasis 
(Gravdal et al., 2007). Taken together, up-regulated N-cadherin together with down-regulated E-
cadherin plays an essential role in the initiation of prostate cancer progression. 
 
Invasion 
 To accomplish the process of invasion, epithelial-mesenchymal transition is needed to 
help cancer cells migrate, and degradation of extracellular matrix (ECM) is essential to release 
the migratory cells from their original site. The degradation of ECM is regulated or executed by a 
wide variety of proteinases, including commonly studied matrix metalloproteinases (MMPs) and 
urokinase-type plasminogen (uPA) (reviewed in Hanahan & Weinberg, 2000; Arya et al., 2006).  
   Matrix metalloproteinases (MMPs) are zinc-dependent proteinases responsible for the 
degradation of collagen, including extracellular matrix (ECM). Up-regulation of MMPs could 
result in progression of cancers (Page-McCaw et al., 2007). The Lichtinghagen group (2002) 
found significant increase in MMP-9 protein expression and unchanged MMP-2 level in 
cancerous parts of 17 prostate samples from radical prostatectomy (Lichtinghagen et al., 2002). 
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The Xiao group (2012) indicates that inhibition of MMP-2 or MMP-9 by siRNA led to inhibited 
invasiveness of PC-3 cells (Xiao et al., 2012). Reis and others (2012) analyzed the prostate tissues 
from 79 prostate cancer patients who underwent radical prostatectomy. They found that 
prostates with higher Gleason Scores (≥7, more aggressive) had higher mRNA expression of 
MMP-2 and MMP-14 (Reis et al., 2012). Overall, the previous studies have shown up-regulation 
of certain kinds of MMPs was related to malignancy of prostate cancer and inhibition of MMP-2 
and MMP-9 resulted in decreased invasiveness in prostate cancer cells, meaning that MMP 
proteins may be involved in cancer progression in prostate. 
 Urokinase-type plasminogen activator, or uPA, is a serine proteinase catalyzing 
plasminogen to a potent prostease, plasmin, which participates in the signaling and execution of 
ECM degradation (reviewed in Arya et al., 2006). Rats implanted with adenocarcinoma 
overexpressing uPA were found to have more wide-spread metastases than the control rats 
implanted with adenocarcinoma producing basal level of uPA. Conversely, rats inoculated with 
adenocarcinoma underexpressing uPA showed decreased metastases than the control rats 
(Achbarou et al., 1994). In addition, induction of siRNAs of uPA and/or uPA receptor (uPAR) to 
highly invasive prostate cancer cell line, PC-3, significantly inhibited the invasive ability of cells 
(Pulukuri et al., 2005). Therefore, uPA may be crucial to trigger invasion of prostate cancer.  
 Invasion is a critical step for cancer metastasis. Many studies have indicated that MMPs, 
especially MMP-2, MMP-9 and MMP-14, and uPA play important roles in degrading ECM and 
help prostate cancer invasion. Therefore, these proteins can be the biomarkers to determine the 
invasiveness of prostate cancer. 
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 The current thesis project is focused upon the effects of broccoli bioactives on invasion of 
a common-studied human derived prostate cancer cell line, DU145 cells, in vitro. A Matrigel 
model system (Baba et al., 2000) was chosen for this work. The model mimics the invasion stage 
shown in figure 1.1. 
 
Seed-and-Soil Hypothesis 
 In human, prostate cancer tends to metastasize to bone, lung, and liver (Bubendorf et al., 
2000). The organ preference of cancer metastasis can be illustrated by the seed-and-soil 
hypothesis, which was firstly proposed by Paget in 1889, based on 735 cases of fatal breast 
cancer. Paget (1889) found that the odds of distant organs developing cancer metastases were 
not equal. Thus, he suggested that the spreading of metastatic tumor cells can be explained by 
the analogy of that seeds can spread widely, but only those staying in the favorable soil 
(preferred organ microenvironment) can grow (Paget, 1889). This hypothesis has been well-used 
to explain the preference of cancer metastasis.  
Over decades of investigation with supportive evidence, Fidler (2003) introduced three 
principles to novel seed-and-soil hypothesis. He firstly suggested that the primary neoplasms 
consist of tumor cells with various genotypes and phenotypes. Some genotypes and their 
corresponding phenotypes help tumor cells overcome the obstacles that may encounter during 
metastasis. However, most tumor cells do not have all of the genotypes and associated 
phenotypes needed for metastasis, so most of them are unable to survive. Fidler further 
indicated that metastases are tumor colonies formed by individual tumor cells that survived the 
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sequential steps of metastasis―from invasion to re-colonization. Finally, he stated that the 
development of metastases depends on the microenvironment of different organs, where 
growth factors, together with associated receptors on the cell surface, mediate the formation of 
metastases (Fidler, 2003).  
 Seed-and-soil hypothesis has been used frequently to illustrate metastasis since 1889. 
Although it cannot explain all the cases of metastases, it is still one of the fundamental ideas that 
is worthwhile to understand. 
 
Cruciferous Vegetables 
 Crucifers are the vegetables belonging to the family of Brassicaceae. These 
vegetables―such as broccoli, cauliflower, cabbage, and kale―are widely cultivated and 
consumed around the world. Some epidemiological trials have found that increasing 
consumption of cruciferous vegetables is related to decreasing risk of prostate cancer (Jain et al., 
1999; Cohen, Kristal, & Stanford, 2000; Kolonel et al., 2000); while other studies have not 
(Giovannucci et al., 2003; Key et al., 2004). Although epidemiological studies project inconsistent 
health outcomes of crucifer consumption, researchers continue to evaluate whether cruciferous 
vegetables are potentially protective against prostate cancer. 
 
Broccoli 
  Broccoli (Brassica oleracea var. italica), one of the cruciferous vegetables, is commonly 
consumed in the United States. The per capita total consumption of broccoli in 2013 was 9.2 
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pounds, which is almost six times more than the total consumption was in 1970 (figure 1.2) 
(USDA, 2014). Fresh broccoli is low in fat and devoid of cholesterol; and high in fiber, vitamin C, 
and vitamin K (USDA, 2013) (Table 1.1). Moreover, various broccoli bioactive components―such 
as isothiocyanates, indoles, and flavonols―are thought to have anti-cancer activity. Research 
results from the University of Illinois indicated that 10% broccoli diet lowered prostate tumor 
weight in a xenograft rat model (Canene-Adams et al., 2007). Additionally, a broccoli-containing 
diet, combined with tomato, alleviated the prostatic damage induced by a carcinogen, PhIP (2-
amino-1-methyl-6-phenylimidazo [4,5-B]pyridine), in a rat model (Canene-Adams et al., 2013). 
However, another study from our lab failed to find any significant effect of either 10% standard 
broccoli or glucosinolate-enriched broccoli diets on progression of prostate lesions in the 
transgenic adenocarcinoma of the mouse prostate (TRAMP) model (Liu et al., 2014, in press). 
Canene-Adams’ studies suggested that broccoli may reduce the severity of prostate 
cancer in two different animal models with prostate tumors introduced exogenously, yet Liu’s 
study was not significant using a mouse model that spontaneously develops adenocarcinoma. 
Different outcomes from three studies may be due to different characteristics of animal models 
used among the three studies. Although Liu’s study did not show significance, we are still 
interested in whether broccoli bioactive components can affect the stages of metastatic prostate 
cancer, especially, invasion. Therefore, we examined four bioactive components, sulforaphane, 
indole-3-carbinol, neoglucobrassicin, and quercetin, individually or in selected combinations, and 
evaluated if these bioactives could affect prostate cancer invasion in vitro. 
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Glucosinolates 
 Glucosinolates are a class of sulfur-containing glucosides that contribute to the bitter and 
spicy tastes of cruciferous vegetables. In nature, when cruciferous plants are injured either by 
pathogens or by pests, the damaged tissue will release an enzyme, myrosinase, to hydrolyze 
glucosinolates into bioactive products (figure 1.3), which can mediate the insect-plant 
interactions, and suppress fungal growth (reviewed in Mithen, 1992). Researchers have 
hypothesized that these bioactive products derived from the side chain cleavage of 
glucosinolates are potentially protective against prostate cancer. Therefore, we investigated 
three hydrolyzed products of glucosinolates―glucoraphanin, glucobrassicin, and 
neoglucobrassicin―and evaluated the effects on prostate cancer cell invasion, in vitro. 
 
Sulforaphane 
 Sulforaphane (SF) is an isothiocyanate (ITC) derived from the particular glucosinolate, 
glucoraphanin, through the hydrolysis reaction catalyzed by myrosinase released from injured 
tissue of crucifers (figure 1.4). SF has been considered a chemopreventive agent for cancer due 
to its special role in activation of nuclear factor erythroid 2-related factor 2, or Nrf2 (Reviewed in 
Fahey et al., 1997; Thimmulappa et al., 2002; Juge et al., 2007). Nrf2 is a transcription factor that 
mediates the expression of phase II detoxification enzymes and antioxidant proteins (reviewed in 
Niture et al., 2010). Under normal conditions, Nrf2 is inactivated and retained in the cytosol due 
to binding to actin-bound Kelch-like ECH-associated protein 1, or Keap1, which is responsible for 
signaling the degradation of Nrf2 (reviewed in Kobayashi & Yamamoto, 2006). When a cell is 
exposed to xenobiotics, antioxidants, heavy metals, radiation, electrophiles, or reactive oxygen 
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species (ROS), Nrf2 is released from Keap1, and translocates to nucleus, where Nrf2 binds to the 
DNA sequence termed the antioxidant responsive element, or ARE, triggering the expression of 
enzymes and other proteins involved in detoxification, antioxidation, or ubiquitination, 
protecting the cell against the damage caused by the exposure of stresses (figure 1.5) (reviewed 
in Motohashi & Yamamoto, 2004; Niture et al., 2010). For example, upon the activation of Nrf2, 
several proteins will be expressed, such as NAD(P)H:quinone oxidoreductase 1 (NQO1), 
glutathione S-transferase (GST), glutathione peroxidase and reductase, γ-glutamate cysteine 
ligase (γ-GCL), heme oxygenase (HO-1), multidrug resistance-associated proteins (MRPs), and 
others (reviewed in Niture et al., 2010). NQO1 is a two-electron reductase that is capable of 
detoxifying and reducing the quinones that would otherwise develop into reactive oxygen 
species, or ROS (reviewed in Ross et al., 2000). GST catalyzes the conjugation reaction of 
glutathione with xenobiotics to form less toxic and more hydrophilic products (reviewed in 
Townsend & Tew, 2003). Glutathione peroxidase is involved in the reduction of hydrogen 
peroxide and alkyl hydroperoxides by transferring reducing power from reduced glutathione, 
leaving oxidized glutathione, which is then recycled through reduction by glutathione reductase 
(reviewed in Jurkovič et al., 2008). γ-GCL is the rate-limiting enzyme in glutathione synthesis 
(Griffith, 1999). HO-1 is responsible for breakdown of heme, and one of the metabolites, 
bilirubin, is a potent antioxidant in the human body (reviewed in Morse & Choi, 2005). MRPs 
participate in drug transport (Borst et al., 2000). Taken together, these proteins, activated by 
sulforaphane-induced Nrf2-ARE signaling pathway, are able to help protect the cell from 
oxidative stress and toxicity. 
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 In addition to the induction of the Nrf2-ARE signaling pathway, sulforaphane is capable of 
triggering apoptosis, or programmed cell death, which is a series of events leading to cell death 
that can be induced by cytotoxic substances, DNA damage, or oxidative stress. The typical 
hallmarks of apoptosis are shrinkage of cell and the nucleus, condensation of nuclear chromatin, 
orderly degradation of DNA, and formation of apoptotic bodies, which are then engulfed by 
macrophages (reviewed in Saraste & Pulkki, 2000; Juge et al., 2007). With apoptosis, the human 
body would be less likely to develop abnormal or cancerous cells. 
 Apoptosis is elaborately regulated by a wide variety of proteins, such as caspases, 
cytochrome c, apoptosis protease-activating factor (Apaf-1), bcl-2 family, bax, and others. Up-
regulation of caspases, cytochrome c, Apaf-1, and bax; and down-regulation of bcl-2, are thought 
to stimulate apoptosis (reviewed in Saraste & Pulkki, 2000; Singh et al., 2004; Juge et al., 2007). 
Research done by Chiao (2002) showed that the apoptotic cells of human prostate cancer cell 
line, LNCaP, were dramatically increased with the treatment of 9µM and 50µM SF. Furthermore, 
the caspase positive cells were much more in the SF-treated group than in control group (Chiao 
et al., 2002). Singh (2004), based on their in vitro study of PC-3 human prostate cancer cells, 
indicated that 20µM and 40µM SF treatments significantly induced DNA fragmentation in PC-3 
cells. Additionally, 20µM SF treatment significantly down-regulated bcl-2 and up-regulated bax 
protein expression in PC-3 cells, which is considered to trigger apoptosis. The same study also 
investigated the involvement of caspases, and it was found that caspases 3 and 9 were up-
regulated after 16 hours of SF (20µM) treatment in PC-3 cells, meaning that the activity of 
apoptosis was increased by sulforaphane treatment (Singh et al., 2004). Singh (2009) also found 
similar results of DNA fragmentation, lowered bcl-2, and increased bax expression in the TRAMP-
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C1 cell (the mouse prostate cancer cell line derived from transgenic adenocarcinoma mouse of 
model, or TRAMP) treated with 20µM SF (Singh et al., 2009). Choi (2007) observed increased 
apoptosis along with elevated expression of apoptosis protease activation factor-1 (Apaf-1), a 
triggering factor that may lead to apoptosis, in both PC-3 and LNCaP cells treated with SF (10-
40µM) (Choi et al., 2007). Taken together, these in vitro studies suggest that sulforaphane can 
induce apoptosis through regulation of various proteins participating in apoptosis, which then 
protect the body against carcinogenesis (figure 1.6). 
The anti-cancer activity of sulforaphane is supported by animal studies. The Singh group 
(2004) used a xenograft mouse model implanted with human prostate cancer, PC-3, and found 
that mice gavaged with 5.6µmol SF three times per week had significantly lower prostate tumor 
volumes than the control mice gavaged with the vehicle (Singh et al., 2004). The same group 
further reported that mice fed with 6 µmol SF three times per week through gavage have lower 
incidence of prostatic intraepithelial neoplasia (PIN) and well-differentiated carcinoma, and 
lower incidence of metastases in lung in TRAMP mice than control mice gavaged with vehicle 
(Singh et al., 2009). 
Although many studies have reported that high levels of SF significantly inhibited cancer 
development, little work has been done using more physiological doses of SF. Therefore, in this 
work, we investigated the influence of physiologically-relevant levels of SF on invasion of 
prostate cancer cell line, DU145, in vitro. 
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Indole-3-Carbinol 
 Indole-3-carbinol (I3C) is a hydrolysis product from glucobrasscin catalyzed by myrosinase 
(figure 1.7). Under acidic conditions (e.g. stomach), I3C spontaneously undergoes condensation 
reaction, forming polymeric products, mainly 3,3’-diindolylmethane (DIM) (figure 1.8). Both I3C 
and DIM are chemopreventive agents of prostate cancer by inducing detoxification and 
suppressing cell growth. Li (2003) indicates that 100 µM I3C and 60 µM DIM significantly 
suppressed PC-3 cell growth in the first 24 hour; while lower concentrations of I3C (30 µM) and 
DIM (30 µM) showed cell growth-suppressive ability at both 48 and 72 hour. Furthermore, the 
gene expression profile of PC-3 cells treated with 60 µM I3C or 40 µM DIM suggested that both 
I3C and DIM were able to up-regulate gene expression related to phase I and phase II 
detoxification enzymes, and down-regulated gene expression that was responsible for the 
regulation of cell growth, proliferation, and apoptosis (Li et al., 2003). Obviously, DIM appeared 
to be more potent than I3C in this study, as DIM was effective in lower concentrations. 
Nachshon-Kedmi (2003) examined the bioactivity of I3C and DIM in three human prostate cancer 
cell lines: PC-3, LNCaP, and DU145. The IC50 values of cell viability with I3C were 150 µM for 
LNCaP, 160 µM for DU145, and 285 µM for PC-3; with DIM were 40 µM for LNCaP, 20 µM for 
DU145, and 40 µM for PC-3, providing more support for the hypothesis that DIM indeed is a 
more potent chemopreventive agent than I3C (Nachshon-Kedmi et al., 2003). 
 The bioactivity of I3C and DIM may be also related to induction of apoptosis. Chinni 
(2001) found that rather high I3C treatments (60µM and 100µM)  in PC-3 human prostate cancer 
cells induced G1 cell cycle arrest (100µM), and up-regulation of bax and down-regulation of bcl-
2, which led to apoptosis (Chinni et al., 2001). The Nachshon-Kedmi group in 2004 reported that 
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DIM (75µM) induced activities of caspases -3, -6, and -9 as well as increasing cytosolic 
cytochrome c in PC-3 cells , which, taken together, leads to apoptosis (figure 1.9). It was 
reported that DIM can trigger apoptosis through inactivation of the PI3K/Akt pathway. PI3K is the 
kinase that phosphorylates and activates Akt. Akt, or protein kinase B, is responsible for 
inhibition of apoptosis. Phosphorylated activation of Akt can stimulate apoptosis. The Li group 
indicates that DIM- treated PC-3 cells have lower PI3K activity, which can also inhibit Akt activity, 
and leads to apoptosis (figure 1.9) (Li et al., 2005). Since apoptosis is a natural defensive 
mechanism to prevent cancer formation, I3C and DIM, which potentially trigger apoptosis of 
prostate cancer cells, can be considered chemopreventive agents against prostate cancer. 
 Many studies have examined the bioactive effect of I3C or DIM on cell growth or 
apoptosis. However, there is a lack of literature looking at the effect of I3C on prostate cancer 
invasion. Therefore, we performed a trial examining the potential bioactivity of I3C on 
suppressing prostate cancer cell invasion, in vitro.  
 
Neoglucobrassicin 
Neoglucobrassicin (NGB) is one of indole glucosinolates present in broccoli. The level of 
NGB in broccoli changes during plant development. Broccoli sprouts contains relatively lower 
level of NGB (Shapiro et al., 2001) in comparison to mature broccoli, when NGB becomes 
predominant (Hansen et al., 1995). Similar to other indole glucosinolates, NGB can be hydrolyzed 
by myrosinase into its corresponding cabinol, N-methoxyindole-3-carbinol (NI3C) (figure 1.10). 
There has been a lack of studies about the biological effects of NGB and its hydrolyzed product. 
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Vo (2014) found that synthetic NGB significantly inhibited lipopolysaccharide-induced 
inflammation through decrease in TNF-α expression in the THP1 Human monocyte cell line with 
the levels of 10µM and 15µM (Vo et al., 2014). However, Haack (2010) observed that the 
hydrolyzed product of NGB, hNGB, decreased NQO1 activity at the concentration of 7.5µM, and 
weakened the anti-cancer properties of the hydrolyzed product of glucoraphanin, SF. For 
example, hNGB reduced SF-mediate Gpx2 gene expression, SF-stimulated Gpx2 promoter 
activity, and SF-induced NQO1 activity (Haack et al., 2010).  
Since only a few studies of NGB have been completed and the literature is limited, the 
function and the effect of NGB remains unclear and needs more investigation. Overall, the 
limited work might suggest that NGB may not have any ability to inhibit prostate cancer 
metastasis. 
 
Flavonols 
 Flavonols are a class of flavonoids composed of a 3-hydroxyflavone backbone (figure 
1.11A) with phenolic hydroxyl groups in different positions that determine the activity of these 
compounds (figure 1.11B, 1.11C). Flavonols exist commonly in a wide variety of fruits and 
vegetables, including broccoli (Bhagwat et al., 2014). In plants, flavonols act as the UV-B filter to 
protect plants from sunlight damage (Agati et al., 2011), and also behave as antioxidants to 
scavenge free radicals induced by sunlight exposure (Agati et al., 2009). In humans, high 
consumption of flavonols is related to lower incidence of multiple cancers, including prostate 
cancer (Knekt et al., 2002). Therefore, we were interested to determine if quercetin, the most 
abundant flavonol in vegetables and fruits, could suppress prostate cancer cell invasion, in vitro. 
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Quercetin 
 Quercetin (Q), a flavonol present in a wide variety of vegetables and fruits (table 1.2), 
predominately exists in the form of quercetin-3-Ο-sophoroside in broccoli (figure 1.12) at levels 
estimated to be approximately 6.5mg/100g broccoli (Vallejo et al., 2004). The typical intake of Q 
ranges from less than 5mg/day to ~40mg/day; however, high-end consumers of non-peeled 
vegetables or fruits could obtain 200-500 mg/day of Q (reviewed in Harwood et al., 2007). Q is 
believed to have antioxidant properties that can scavenge reactive oxygen species (ROS) 
(Afanas’ev et al., 1989). ROS are oxygen-centered free radicals what the body can be exposed to 
either exogenously, through environmental stress, or endogenously, through respiration. 
Common ROS, including superoxide (O2●-), peroxyl (ROO●), alkoxyl (RO●), hydroxyl (HO●), and 
nitric oxide (NO●), are so reactive that once generated, they can immediately oxidize nearby cell 
membranes, proteins or enzymes, or DNA, resulting in cell membrane damage, protein or 
enzyme structural modifications, and/or gene mutations. The accumulation of this damage is 
considered to be part of the reason for aging, inflammation, and several degenerative diseases, 
such as cardiovascular disease, hepatic disease, and cancer (Pietta, 2000; Blake, 1995). Q is 
thought to be capable of neutralizing oxidative stress by chelating the transition metals involved 
in the generation of ROS. Additionally, the phenolic hydroxyl groups of Q may act as electron 
donors to scavenge free radicals (Bors et al., 1990). Moreover, a study done by Tanigawa (2007) 
using HepG2 liver cancer cell line indicated that Q increased ARE activity by decreasing KEAP1 
protein levels, increasing Nrf2 mRNA expression, stabilizing Nrf2 from being degraded as well as 
triggering Nrf2 to translocate from cytosol to nucleus, where Nrf2 binds to ARE and stimulate the 
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expression of downstream gene such as NQO1, a protein that helps scavenge of ROS (Tanigawa 
et al., 2007). Thus, Q apparently is a good dietary antioxidant that can slow down the 
accumulation of oxidative stress in the body.  
Flavonoid glycosides are generally poorly absorbed by the enterocytes in the intestine. 
Therefore, they must be hydrolyzed, by enterobacteria, into the aglycone form to facilitate the 
absorption, which mostly happens in the colon, where the flavonoid may also be degraded 
(Murota & Terao, 2003). However, Q may be different than other flavonoids. Hollman (1995) 
suggested that Q was better absorbed in glycoside forms than in the aglycone form in ileostomy 
volunteers who do not have colonic bacteria (Hollman et al., 1995). To elucidate Hollman’s 
(1995) case, researchers based on their studies indicate that the bioavailability of Q depends on 
the different position and variety of sugar moiety attached, as the glucose transporter system 
may be responsible for Q glycosides absorption (Hollman et al., 1997; Arts et al., 2004). Different 
sugar attached would also change lipophilicity of the entire compound, and affect absorption 
(Murota & Terao, 2003). While part of the Q glycosides are absorbed in small intestine, the rest 
may be hydrolyzed or degraded into metabolites by bacteria in colon prior to absorption (Crozier 
et al., 2009). After consumption of Q form dietary sources, such as onions, only quercetin 
glucurionides and quercetin sulfides can be found in human plasma (Wittig et al., 2001; Janisch 
et al., 2004), Moon et al. (2001) further examined the antioxidant ability of some quercetin 
glucurionides, and found that these quercetin glucurionides still have antioxidant ability to 
scavenge free radicals (Moon et al., 2001).  
The epidemiological study suggests that health outcomes were related to quartiles of Q 
consumption per day. Q intake was inversely associated with mortality of ischemic heart disease 
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(4th quartile), risk of diabetes (2nd, 3rd quartiles) and all cancers (4th quartile), especially lung 
cancer (2nd, 3rd, 4th quartiles) (Knekt et al., 2002). Animal studies showed that the Q-containing 
diet (200mg/kg body weight) significantly reduced the incidence of prostatic tumor induced by 
the combination of a carcinogen (N-methyl-N-nitrosourea, or NMU) and testosterone in a rat 
model (Sharmila et al., 2014). In addition, Pratheeshkumar (2012) found that a diet containing Q 
(20mg/kg/day) significantly inhibited prostate tumor growth in a xenograft mouse model 
(Pratheeshkumar et al., 2012). The anti-cancer property of Q was also seen in cell culture 
studies. Q was able to suppress cell viability of PC-3 human prostate cancer cells (treated with 
20µM-50µM Q) (Pratheeshkumar et al., 2012), and inhibited colony formation of highly invasive 
cell lines, DU145 and PC-3 (treated with 25µM and 50µM Q), but not in the non-invasive cell line, 
LNCaP (Nair et al., 2004). The result from Nair’s study (2004) indicates that Q may particularly 
target invasive prostate cancer. On the other hand, Pratheeshkumar treated highly progressive 
prostate cancer cell line, PC-3, with Q (30µM and 40µM), and detected decreased secretion of 
vascular epithelial growth factor (VEGF), which is involved in cancer progression 
(Pratheeshkumar et al., 2012). Furthermore, Senthilkumar found reduced migration/invasion-
related mRNA expression, such as urokinase-type plasminogen activator (uPA), uPA receptor 
(uPAR), epidermal growth factor (EGF), and EGF receptor (EGFR) in PC-3 cells (Senthilkumar et 
al., 2011). Collectively, literature suggests that Q is one of the components in broccoli that may 
potentially suppress prostate cancer invasion. Previous studies mainly investigated effects of 
supplement Q at high levels, but little study has been done with physiologically-relevant levels. 
Thus, in this work we examined the effect of Q on prostate cancer cell invasion in vitro at levels 
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that might be expected in blood following dietary intake of Q-containing foods or low dose 
supplements.    
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Figures and Tables 
Figures 
 
Figure 1.1. The scheme of metastasis (Weinberg, 2014). EMT represents epithelial-mesenchymal 
transition, and MET represents mesenchymal-epithelial transition. 
 
 
Figure1.2. US per capita consumption of total, fresh, and processed broccoli during 1970-2013 
(USDA, 2014) 
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Glucosinolate 
Figure 1.3. The structure of glucosinolate. 
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Figure 1.4. The hydrolysis reaction of glucoraphanin into sulforaphane. 
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Figure 1.5. The activation of Nrf2-ARE signaling by sulforaphane according to previous studies.  
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Figure 1.6. The possible apoptosis cascade induced by sulforaphane according to previous 
studies. 
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Figure 1.7. The hydrolysis reaction of glucobrassicin into indole-3-carbinol. 
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Indole-3-Carbinol 
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3,3'-Diindolylmethane 
Figure 1.8. The condensation reaction of indole-3-carbinol (I3C) into 3,3’-Diinolylmethane (DIM). 
 
 
Figure 1.9. The DIM-induced apoptosis pathway according to the literature. 
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Neoglucobrassicin 
Myrosinase 
 
H2O 
 
 
 
N-methoxyindole-3-carbinol 
+ Glucose 
+ -NCS 
Figure 1.10. The hydrolysis reaction of neoglucobrassicin into N-methoxyindole-3-carbinol. 
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Flavonol 
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Figure 1.11. A. The structure of 3-hydroxyflavone backbone in flavonols. B. The structure of 
flavonols. C. Examples of different flavonols with various R1 and R2 groups, such as myricetin, 
kaempferol, isohamnetin, and luteolin (Crozier et al., 2000). 
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Figure 1.12. The hydrolysis reaction of quercetin-3-Ο-sophoroside into quercetin aglycone.  
 
Table 
Table1.1. The nutrition content of raw broccoli (edible portion). Data were obtained from USDA 
National Nutrient Database for Standard Reference, Release 26 (2013). 
Nutritional Value in 100 g (3.5 oz) 
 Amount %DV  Amount %DV 
Energy 34kcal 2%   Zinc 0.4mg 3% 
Water 89.3g    Manganese 0.2mg 10% 
Protein 2.8g 6%   Selenium 2.5µg 4% 
Cholesterol 0.0mg 0% Vitamins   
Total fat 0.4g 1%   Vitamin A 623 IU 12% 
Total carbohydrate 6.6g 2%   Vitamin C 89.2mg 149% 
  Dietary fiber 2.6g 10%   Vitamin E 0.8mg 4% 
  Sugar, total 1.7g    Vitamin K 102µg 127% 
Minerals     Thiamin (B1) 0.1mg 5% 
  Calcium 47mg 5%   Riboflavin (B2) 0.1mg 7% 
  Iron 0.7mg 4%   Niacin (B3) 0.6mg 3% 
  Magnesium 21.0mg 5%   Vitamin B6 0.2mg 9% 
  Phosphorous 66mg 7%   Folate 63.0µg 16% 
  Potassium 316mg 9%   Pantothenic Acid (B5) 0.6mg 6% 
  Sodium 33mg 1%    
 
Quercetin-3-Ο-sophoroside 
 
 
 
Bacterial enzymes 
 
  
Quercetin 
 
 
+ Sophorose 
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Table 1.2. Quercetin content in fruits and vegetables. Data were obtained from USDA Database 
for the Flavonoid Content of Selected Foods, Release 3.1 (2014). 
 
Quercetin Content (mg/100g of edible portion) 
Food Content (Mean) Food Content (Mean) 
Capers, raw 233.84 Blueberries, raw 7.67 
Radish leaves, raw 70.37 Oregano, fresh 7.30 
Red onions, raw 31.77 Chives, raw 4.77 
Watercress, raw 29.99 Pears, raw 4.24 
Elderberries, raw 26.77 Spinach, raw 3.97 
Kale, raw 22.58 Blackberries, raw 3.58 
Onions, raw 21.40 Broccoli, raw 3.26 
Okra, raw 20.97 Bay leaves, fresh 3.19 
Bee pollen 20.95 Cherry tomatoes, raw 2.76 
Apple, skin only 19.36 Green tea, brewed 2.49 
Chia seeds, raw 18.42 Grapes, black 2.08 
Sweet potato leaves, raw 16.94 Chinese cabbage, raw 2.12 
Cranberries, raw 14.84 Brussels sprouts, raw 1.92 
Asparagus, raw 13.98 Garlic, raw 1.74 
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Chapter II 
Effect of Broccoli Bioactives on Prostate Cancer Invasion in vitro 
Abstract 
 Prostate cancer is the second leading cause of cancer-related deaths in males in the 
United States. Epidemiological studies suggest that high intake of cruciferous vegetables is 
associated with lower incidence and lower progression of prostate cancer. It has been found that 
these crucifers, especially broccoli, contain abundant bioactive components that may possess 
anti-cancer properties. However, little research has been completed regarding which 
components play significant roles in suppression of prostate cancer development, from 
progression to metastasis. Here, we performed the Matrigel invasion assay to examine effects of 
four abundant bioactive components in broccoli: sulforaphane (SF), indole-3-carbinol (I3C), 
hydrolyzed neoglucobrassicin (hNGB), and quercetin (Q) individually, or in selected 
combinations. DU145 invasive human prostate cancer cells were plated into the Matrigel 
invasion chambers inserted in 24-well plates, together with a chemo-attractant. The suspension 
medium in the chambers was replaced with treatments after cells attached to the Matrigel. After 
a total of 48 hour treatment exposure, with the treatments renewed at the 24th hour, invading 
cells were fixed, stained, and counted. Results show that 3µM-5µM SF or 160-200nM I3C 
significantly suppressed DU145 cell invasion; whereas NGB (1-50µM) and Q (1-5µM), did not. In 
the study combining 5µM SF with 120nM I3C shows significant inhibition of DU145 cell invasion. 
However, there was no significant difference between the combination treatments and 5µM SF 
alone, suggesting that the combination of SF and I3C did not synergistically or additively affect 
DU145 cell invasion. To verify whether the reduction of invading cells caused by SF and I3C, 
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individually, was due to the suppression of invasiveness or cell death, we further performed a 
test for cell viability using the MTT assay. Cells were seeded in 96-well plates, followed by the 
treatment procedure as described in the Matrigel invasion assay. After 48 hour incubation, MTT 
(3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) was added to each well, followed 
by 4-6 hour incubation. The result indicated that the invasion-suppressive concentrations of SF 
and I3C did not decrease cell viability, meaning that SF and I3C suppressed cell invasion not by 
causing cell deaths, but by inhibiting the invasive ability of DU145 cells. The mechanism of how 
SF and I3C suppressed DU145 cell invasion needs to be further studied in the future. 
 
Introduction 
 Prostate cancer has been estimated to be the second leading cause of cancer-related 
deaths in men in the United States in 2014 (Siegel et al., 2014). The five-year relative survival 
rate of men with localized or regional prostate cancer is 100%; however, for those with 
metastatic prostate cancer, was only 28% (Siegel et al., 2014). Several environmental factors 
have been found to be influential in prostate cancer incidence and mortality. For example, age 
(Bostwick et al., 2004), race (Siegel et al., 2014), region of residency (Kamangar, 2006; John et al., 
2007), sun exposure (Hanchette & Schwartz, 1992), family history (Frank et al., 2014), and diet 
(Kolonel, 2001; Giovannucci et al., 2003; Nelson et al., 2014). One of the manageable factors is 
diet. Epidemiological studies have suggested that high intake of meat products may increase the 
risk of prostate cancer (Kolonel, 2001); while high intake of fruits and vegetables may reduce the 
risk of prostate cancer (Giovannucci et al., 2003; Nelson et al., 2014). Cruciferous vegetables, or 
Brassicaceae plants, contain abundant bioactive compounds that are considered to make a 
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contribution to the decrease in the risk of prostate cancer (Jain et al., 1999; Cohen et al., 2000; 
Kolonel et al., 2000). Broccoli, one of the crucifers with high levels of glucosinolates and 
flavonols, is thought to be a cancer-preventive vegetable. Although Liu (2014) failed to find any 
effect of a broccoli supplemented diet on prostate tumor growth in a transgenic mouse model 
that develops prostate cancer spontaneously (Liu et al., 2014, in press), Canene-Adams observed 
that a 10% broccoli diet significantly lowered prostate tumor weight in rats that were implanted 
with prostate tumors (Canene-Adams et al., 2007). Additionally, Canene-Adams indicated that a 
diet containing broccoli and tomato significantly reduced prostate lesions in rats fed carcinogen 
(Canene-Adams et al., 2013). Over all, the data support a hypothesis that broccoli could be 
preventive against prostate cancer. 
 Although broccoli has been shown to suppress prostate cancer growth in some animal 
models, the effect of the main bioactive broccoli components on inhibition of prostate cancer 
invasion needs investigation. The purpose of this study was to examine effects of four bioactives 
abundantly present in broccoli―sulforaphane (SF), indole-3-carbinol (I3C), hydrolyzed 
neoglucobrassicin (hNGB), and quercetin (Q)―on prostate cancer cell invasion. The Matrigel 
invasion assay was performed to investigate suppressive abilities of these four bioactives, 
individually, or in combination (Baba et al., 2000). MTT assay was also conducted to confirm 
whether the decrease in invading cells was caused by the invasion-suppressive ability or by the 
cytotoxicity of these bioactives. The invasive human prostate cancer cell line, DU145, was used 
as the experimental model. 
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Materials and Methods 
Cell Culture 
 In this study, DU145 cells were used as an in vitro prostate cancer model. DU145 is a 
metastatic prostate cancer cell line derived from the brain tissue of a 69-year-old male Caucasian 
(Stone et al., 1978). Previous studies have found that this cell line has a high invasive ability and 
adherent growth properties (Hoosein et al., 1991). The doubling time of DU145 cells ranges from 
23.8 to 40.3 hours (Ware et al., 2007). Because of its characteristics―high invasive ability, 
adherent growth pattern, and adequate doubling time―DU145 was selected to examine the 
potency of broccoli bioactive compounds on inhibition of prostate cancer invasion. 
DU145 cells (American Type Culture Collection, or ATCC) were cultured in 75 cm2 cell 
culture flasks (Corning) in Eagle’s Minimum Essential Medium (EMEM) (ATCC), with 10% fetal 
bovine serum (FBS) (BenchMark), and 1% antibiotics composed of 100U/mL penicillin (Sigma-
Aldrich) and 100mg/mL streptomycin (Sigma-Aldrich). The cell culture medium was renewed 
every 2-3 days. Once reaching 80%-90% of confluence, cells were harvested with 0.25% 
trypsin/0.02% EDTA solution, and passed to new flasks at the ratio of 1:5 to 1:10. All cell culture 
flasks were incubated in a humidified atmosphere with 5% CO2 and 95% air at 37°C. Prior to the 
any study in this work, DU145 cells were starved with EMEM/0.1%BSA for 24 hours, in order to 
synchronize the cell cycle of stock cell, and minimize the variability caused by different stages of 
the cell cycle when cells grow. 
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Treatment Preparation 
Sulforaphane (LKT laboratories), indole-3-carbinol (Sigma-Aldrich), 3,3’-diindolylmethane 
(Sigma-Aldrich), and quercetin (Sigma-Aldrich) were freshly made, dissolved in DMSO, and stored 
at -20°C, 4°C, and room temperature, respectively. Hydrolyzed neoglucobrassicin (extracted and 
purified by Dr. Berhow; ARS, USDA) was also freshly made by directly dissolving neoglucobrasscin 
in the EMEM with 20mU/mL myrosinase (Sigma-Aldrich).  
 
Cell Counting Procedure for Plating 
 To count cells, duplicate cell counting solutions were made by adding 100 µL of well-
suspended cells to each Eppendorf tube containing 570 µL of PBS and 330 µL of Trypan Blue. 
After mixing several times with a Pasteur pipet, the solution was placed into a hemocytometer. 
Cells in five fields (the shaded squares in Figure 2.1) were counted using a microscope. Each 
sample of cells was counted five times in separate hemocytometers. The calculation of cell 
number is displayed in calculation 2.1. All results from the duplications were averaged. Based on 
the averaged result, cell suspensions were diluted, using medium, to the desired concentration 
(5×104 cells/mL for Matrigel invasion assay and 1.25×105 cells/mL for the MTT assay). 
 
Determine a Chemoattractant for Matrigel Invasion Assay 
 In order to choose a suitable chemoattractant that stimulates DU145 cell invasion, the 
Matrigel invasion assay was performed as previously described (Baba et al., 2000), with 
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modifications. After 24-hour starvation with EMEM/0.1% BSA, 2.5×104 cells (subcultured no 
more than 10 generations) were plated in Matrigel chambers (BD Bioscience) placed in 24-well 
plates with 100ng/mL epidermal growth factor (EGF) dissolved in EMEM or complete growth 
medium (EMEM/10% FBS) as the chemoattractant in the bottom wells, followed by a 48-hour 
incubation in an incubator with a humidified atmosphere with 5% CO2 and 95% air at 37°C. After 
incubation, invading cells were fixed, stained, and observed under a microscope at the 
magnification of 200X. Seven light fields of each membrane were randomly selected, and cells in 
the light fields were counted. 
 
Invasive Ability of DU145 by Matrigel Invasion Assay 
 The invasive ability of DU145 cells was examined by an invasion assay (Figure 2.2), which 
was carried out as previously described (Baba et al., 2000), with some modifications. Basically, 
DU145 cells underwent serum depletion with EMEM/0.1% BSA for 24 hours prior to the invasion 
assay. Cells were then harvested with 0.25% trypsin/0.02% EDTA solution and plated, at a 
concentration of 5×104 cells/mL, into Matrigel invasion chambers with the Matrigel layer on the 
porous membrane (pore size, 0.8µM). The Matrigel invasion chambers were placed in the 24-
well plate with complete growth medium as the chemoattractant in each well. After incubation 
for 12, 24, 36, and 48 hours, non-invading cells were removed by swabbing with cotton swabs, 
while invading cells were fixed with anhydrous methanol blue (Sigma-Aldrich), stained with 1% 
toluidine blue (Sigma-Aldrich) , and counted in 7 randomly selected microscope light areas at the 
magnification of 200X. The sum of 7 fields was averaged, and is shown in the result. 
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Effect of Individual Broccoli Bioactives on DU145 Cell Invasion 
 The goal of the invasion assay was to determine the ability of bioactives to suppress 
DU145 invasion. DU145 cells were starved, harvested, and plated as previously described. After 
cells attached to the Matrigel, medium in the chambers was randomly replaced with treatments 
(SF , I3C , DIM, and Q in DMSO, diluted by EMEM/0.1% BSA to the desired concentrations, or 
NGB, diluted by EMEM/0.1% BSA with 20Mu/mL myrosinase to the desired concentrations) or 
control solutions (EMEM/0.1% BSA with DMSO, for trials of SF, I3C, DIM, and Q; or EMEM/0.1% 
BSA with 20mU/mL myrosinase, for the trial of NGB). Plates were then incubated for 24 hours in 
a humidified atmosphere with 5% CO2 and 95% air at 37°C. After 24 hours, all treatments were 
renewed, and cells were incubated for another 24 hours to reach a total of 48 hour exposure 
time. Finally, Matrigel along with non-invading cells were gently removed by swabbing with 
cotton tips; and invading cells on the bottom of the membrane were fixed with methanol, 
stained with toluidine blue, and counted in 7 randomly chosen microscope light fields at a 
magnification of 200×. The results were then standardized by the mean of DMSO or control 
groups, and shown in the form of percent invasion. 
 
Effect of Broccoli Bioactives in Combination on DU145 Cell Invasion 
 The purpose of this experiment was to investigate whether broccoli bioactives in selected 
combinations additively or synergistically affect DU145 cell invasion. The Matrigel invasion assay 
was performed as previously described (Baba et al., 2000); except the treatments were the 
selected bioactives in combinations (fixed level of SF (2µM) combined with increasing levels of 
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I3C (80, 120, 160, and 200nM), or sequential levels of SF (2, 3, 4, 5 µM) combined with fixed level 
of I3C (120nM)). At the end of the 48 hour treatment exposure, with treatments renewed at the 
24th hour, non-invading cells were removed by cotton swabs, and invading cells were fixed, 
stained, and counted. The results were shown as the percent invasion. 
 
Cell Viability: MTT Assay 
 To examine whether the decrease in the number of invading cells was influenced by cell 
viability, the MTT assay was used to test the cytotoxicity of effective treatments. The principle of 
MTT assay is based on the color change of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl 
tetrazolium bromide) caused by mitochondrial activity in living cells, where MTT is converted 
into insoluble purple formazan crystals, which can dissolve in solubilization solutions, such as 
acidified isopropanol, and form colored complex that are further analyzed by spectrometer (van 
Meerloo et al., 2011). 
 In this work, we performed the MTT assay according to previous studies (van Meerloo et 
al., 2011; Uslu et al., 1997), with modifications to mimic the procedure described in the Matrigel 
invasion assay. Prior to the MTT assay, DU145 cells were starved with EMEM/0.1% BSA for 24 
hours. Then 12,500 of DU145 cells in 100µL of EMEM/0.1% BSA were seeded into 96-well flat 
bottom plates with 150µL of EMEM/10% FBS, and incubated for 2-3 hours. After cells attached 
to the bottom, suspension medium was replaced by 200µL of treatments (3µM, 4µM, 5µM, 
10µM SF; and 160nM, 200nM, 1µM I3C dissolved in DMSO, with the concentration of DMSO not 
exceeding 0.1% of the final solution) dissolved in the solution containing 60% complete medium, 
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and 40% EMEM/0.1% BSA, which simulates the composition of the chemoattractant in the 
bottom wells and the suspension medium in upper inserts. All the treatments were conducted in 
triplicate. Medium alone served as the blank (n=6); cells without any treatment served as 
positive control (n=6); while treatments without cells served as reagent control (n=3), which 
were subtracted from the result to minimize the effects of treatments and reagents on 
absorbance reading. The 96-well plate, then, was incubated in a humidified atmosphere with 5% 
CO2 and 95% air at 37°C. In order to simulate the conditions used for the Matrigel invasion assay 
in our study previously described, all the treatments were renewed at the 24th hour, and 
incubated for another 24 hours. After a total of 48 hour treatment exposure, 20µL MTT was 
added to each well, and the plate was shaken for 5 minutes before incubation for 4-6 hours. 
Then unreactive supernatant was replaced by 150µL of acidified isopropanol, which dissolves the 
formazan crystals, and forms a colored solution. All the samples, controls, and blanks were 
moved to a new 96-well plate. Finally, the new plate with samples, controls, and blanks was 
analyzed using a plate reader (µQuant, MQX200, Bio-Tek Instruments, Inc., Winooski, Vermont) 
at 540nm and 720nm. The OD720nm values were subtracted from OD540nm values to minimize the 
background noise. The OD720nm-540nm values were further adjusted by the blank and reagent 
controls. 
 
Statistical Analysis 
 The results were statistically analyzed by SAS 9.3 (Cary, NC) using one-way ANOVA 
followed by LSD test with α=0.05. Significant differences are displayed with different letters 
37 
 
when sample sets have the same N, or with an asterisk when sample sets have different N. All 
the results are displayed as mean ± SEM. Linear regression analysis by SAS 9.3 (Cary, NC) was 
used for the study of I3C to determine the relationship between dose and percent invasion. 
 
Results 
EMEM/ 10% FBS was selected as the Chemoattractant for the Matrigel Invasion Assay 
 To select a suitable chemoattractant for the Matrigel invasion assay, epidermal growth 
factor (EGF) and complete growth medium (EMEM/10% FBS) were tested by the Matrigel 
invasion assay. The DU145 cell line was reported to have androgen receptors (AR) on the cell 
membrane. EGF is one of the ligands that can trigger cell invasion through AR (Alimirah et al., 
2006). Therefore, EGF was chosen as one of the candidate chemoattractants. On the other hand, 
several previous studies used complete growth medium as a chemoattractant to stimulate cell 
invasion (Shen et al., 2010; Petersen et al., 2012; Guo et al., 2013), so we also selected it as 
another candidate chemoattractant.  
In this study, 2.5×104 cells were seeded in Matrigel invasion chambers placed in the 24-
well plates with 100ng/mL EGF in EMEM or 10% FBS in EMEM. After 48 hour incubation, 
invading cells were fixed, stained and counted. The result (Figure 2.3) shows that EMEM with 
10% FBS was better able to induce cell invasion. Therefore, we used EMEM with 10% FBS as the 
chemoattractant in the following studies. 
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48 Hour Treatment Exposure was selected for Matrigel Invasion Assay 
 To examine the invasive ability of DU145 cells, cells were seeded into Matrigel invasion 
chambers after 24-hour starvation. After incubation for 12, 24, 36 and 48 hours, cells were fixed, 
stained, and counted. The suspension medium of samples incubated for more than 24 hours was 
refreshed at the 24th hour. Each time point had 6 replications. The result (Figure 2.4) shows that 
only a few cells invaded by the first 24 hours, but after 36 hours, there was more than a 10-fold 
increase in cell invasion. Since the goal of the work was to test the potency of broccoli bioactives 
to inhibit cell invasion, we desired high enough cell invasion to show the suppressive ability of 
those bioactives, so 12 and 24 hour were not considered. 36 hour was not considered as well, 
for this time point may be the initiation stage of log phase, where cell growth is not stable and 
may cause high variability. Therefore, 48 hour was selected as the exposure time in further 
experiments. 
 
Sulforaphane and Indole-3-Carbinol Suppressed Prostate Cancer Cell Invasion  
To determine whether SF and/or I3C could suppress prostate cancer cell invasion, we 
performed the Matrigel invasion assay with DU145 cells treated with different concentrations of 
SFN (1, 2, 3, 4, 5 µM in 0.1% DMSO), or I3C (40, 80, 120, 160, 200 nM in 0.1% DMSO), using 0.1% 
DMSO as a negative control. All the treatments were diluted by EMEM/0.1% BSA to the desired 
concentrations. Each treatment had 5 replications. 
All the 24-well plates with Matrigel invasion chambers were incubated for 24 hours, and 
treatments as well as DMSO control were refreshed at the 24th hour in order to mimic the 
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condition of daily broccoli consumption. After refreshing treatments, cells were then incubated 
for another 24 hours to achieve a total exposure time of 48 hours.  
SFN and I3C were able to suppress cell invasion at the concentration as low as 3µM 
(Figure 2.5) and 120nM (Figure 2.6A), respectively. Since I3C suppresses prostate cancer cell 
invasion at lower concentration compared to SFN, we can conclude that under the condition of 
the assay that I3C is a more potent bioactive than SFN. In addition, we noted a dose response for 
I3C. Although I3C only shows significance with the concentrations higher than 120nM, linear 
regression analysis (Figure 2.6B) illustrates that as the concentration of I3C increases, the 
invading cell number decreases, with R2=0.93, p<0.01. Therefore, it appeared that the main 
bioactives in broccoli, SFN and I3C, may have the ability to suppress prostate cancer invasion. 
 
Hydrolyzed Neoglucobrassicin and Quercetin Did Not Suppress Prostate Cancer Cell Invasions 
 To investigate if hydrolyzed NGB (hNGB) and Q are able to inhibit prostate cancer 
invasion, the Matrigel invasion assay was carried out essentially as described above, except that 
NGB was dissolved in EMEM/0.1%BSA, and added directly to the medium with myrosinase. Trials 
with 1-5 µM and 10-50µM hNGB were performed in two separate experiments. The results 
indicate that hNGB (Figure 2.7A, 2.7B) treatments over a wide range of concentrations failed to 
significantly suppress prostate cancer cell invasion even at the high concentration of 50 µM, a 
serum/tissue level that is not achievable from diet. Quercetin also did not significantly inhibit 
prostate cancer cell invasion at the levels of 1 to 5 µM (figure 2.8). 
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Sulforaphane Combined with Indole-3-Carbinol Did Not Have Additive Effects 
 We examined SF and I3C, alone or in combination on DU145 cell invasion: 1) using a fixed 
level of SF (2µM), combined with increasing levels of I3C (80, 120, 160, and 200nM) in three 
separate trials, and 2) a fixed level of I3C (120nM), combined with increasing levels of SF (2, 3, 4, 
and 5 µM). In the first set of studies, no significant loss were seen in invasion between the 
treatment combinations and the DMSO control (n=15, 5 of each trial) (figure 2.9). In the second 
set of studies, 5 µM SF alone, or in combination with 120nM, significantly reduced cell invasion 
(figure 2.10). Yet, there was no statistical difference between 5 µM SF treatment and 5 µM SF in 
combination with 120nM I3C, meaning that the combination of SF and I3C did not additively or 
synergistically suppress DU145 cell invasion. 
 
“Aged” I3C was More Potent Than Fresh-Made I3C and DIM 
 According to results testing I3C individually and I3C in combination with SF, we found 
that the outcomes were inconsistent. In the study treating cells with I3C individually had 
significantly lower invasion using 120-200nM treatments (figure 2.6); while in the study treating 
cells with the combination of I3C and SF did not result in a decrease in invasion even with the 
level of 200nM I3C alone (figure 2.9). The differences may be caused by the fact that we used 
the I3C that had been stored for months in the individual study, but used fresh-made I3C in the 
combination study. Since I3C is an unstable compound, it can spontaneously condense to potent 
polymeric products, mainly 3,3’-diindolylmethane (DIM). Therefore, we further compared the 
bioactivity of “aged” I3C, fresh-made I3C, and DIM (with levels equivalent to I3C). The result 
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(figure 2.13) shows that only “aged” I3C significantly inhibited DU145 cell invasion with levels of 
120-200nM, which matches what we previously found. However, fresh-made I3C and DIM did 
not significantly decrease DU145 cell invasion. The “aged” I3C must widely contained DIM and 
additional polymeric products that may act in a synergistic manner to inhibit cell invasion. 
 
Cell Viability of DU145 was not Decreased by the Treatments of SF or I3C 
 The MTT assay was used to determine whether the decrease in invading cells was caused 
by cell death. Therefore, the entire study simulated the condition of the Matrigel invasion assay. 
In short, DU145 cells were starved for 24 hours, followed by seeding, 2-hour incubation, 
treatment (3µM, 4µM, 5µM, and 10µM sulforaphane; and 160nM, 200nM, and 1000nM indole-
3-carbinol), 24-hour incubation, treatment renew, and additionally 24-hour incubation. After a 
total of 48 hour treatment exposure, MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium 
bromide) was added to each well, and incubated for 4 to 6 hours. The purple crystals formed by 
living cells were dissolved by acidified isopropanol, yielding the colored solution. Finally, the 
absorbance of the colored solution was read using a spectrometer.  
 The invasion-suppressive concentrations of SF (3µM, 4µM, and 5µM) and I3C (160nM 
and 200nM) did not reduce cell viability (figure 2.11 and figure 2.12). In other words, the 
decrease in invasion of cells treated with SF or I3C was not likely due to cell death, but due to the 
suppression of invasive ability of DU145 cells. 
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Discussion 
Sulforaphane 
 Sulforaphane (SF) has been considered a potent chemopreventive agent for a number of 
cancer types. Most of previous studies have examined the property of SF using pharmaceutical 
levels for cancer prevention and apoptosis induction. Relatively few studies have looked at 
metastasis suppression, especially with physiologically-achievable levels. Our study indicated 
that 3-5 µM SF significantly inhibited invasion of DU145 cells without causing cell death. 
According to the literature, 3-5 µM SF in the human plasma can be achieved by the consumption 
of 136-227 grams of broccoli (Gasper et al., 2005).  
 We also examined the invasion-suppressive ability of SF combining with I3C. Figure 2.9 
suggests that the combinations, with a fixed concentration of SF (2µM) and increasing 
concentrations of I3C (80nM, 120nM, 160nM, and 200nM), did not significantly inhibit prostate 
cancer cell invasion. This result was pooled from three separate trials, with no significance seen 
in the individual trail. Figure 2.10 demonstrated that 5 µM SF alone, or the combination of 5 µM 
SF and 120 nM I3C significantly inhibited invasion of DU145 cells. In our earlier trial testing SF 
individually, we saw significant decreases in invasion with 3-5 µM SF (figure 2.5). However, in this 
trial combining 3µM, 4µM, or 5 µM SF with 120nM I3C, only the combination of 5 µM with 120 
nM significantly inhibited DU145 cell invasion. These surprising results may be due to 
experimental variability, which needs to be minimized in additional trials.  
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 To understand more about how a mixture of broccoli bioactives may provide added 
benefit, effects of other combinations of bioactives on prostate cancer cell invasion need to be 
investigated in the future.  
 
Indole-3-Carbinol 
 High levels of I3C has been reported to inhibit cell growth and induce apoptosis, yet few 
studies have been carried out regarding the effect of I3C on cancer cell invasion with far lower 
levels. The result of our study showed that 120-200 nM I3C significantly inhibited invasion of 
DU145 cells (figure 2.6). However, it is not clear whether the invasion-suppressive property was 
attributed to I3C or its polymeric products.  
 I3C is an unstable indole, especially in low pH environment such as stomach. Once 
generated, I3C tends to undergo a condensation reaction, forming polymeric products, mostly 
3,3’-diindolylmethane, or DIM. Reed and others (2006) reported that 1 hour after I3C 
supplement intake (400mg and 1000mg), high levels of DIM (61ng/mL and 607ng/mL, 
respectively), but no I3C, could be detected in human plasma (Reed et al., 2006). Although cell 
culture has a different environment than in human bodies, Bradlow and Zeligs (2010) suggested 
that approximately 60% of I3C was converted into DIM at the end of a 24 hour incubation in cell 
culture medium, a pH-neutral environment (Bradlow & Zeligs, 2010). If I3C from broccoli was not 
converted into other compounds after consumption, 115g of broccoli consumption would 
theoretically achieve the level of 120nM in the plasma. Otherwise, 61ng/mL and 607ng/mL DIM 
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could be detected after supplementation of 400mg and 1000mg I3C, respectively. However, we 
do not know how much I3C was in the form of DIM in this study. 
 In our study investigating I3C individually, we treated cells with the I3C that had been 
stored for a few months, and the percent invasion of cells was significantly inhibited (figure 2.6). 
This “aged” I3C appeared to be very bioactive in these assay conditions, as we found no 
significant decrease in invasion of DU145 cells treated with 200nM fresh-made I3C in the study 
treating cells with SF and I3C, alone, or in combinations (figure 2.9). According to Bradlow and 
Zeligs (2010), fresh I3C in medium spontaneously condenses to DIM and other polymeric 
compounds in 24 hours. “Aged” I3C may potentially have a higher composition of DIM and other 
polymeric compounds in comparison to fresh-made I3C that we refreshed every 24 hours in the 
Matrigel invasion assay. Therefore, to compare the potency of fresh I3C, “aged” I3C, and DIM, 
and to verify if the bioactivity of “aged” I3C is mostly attributed to DIM, we conducted the 
Matrigel invasion assay with 80-200nM fresh I3C, 80-200nM “aged” I3C, and 40-100nM DIM 
(equivalent to 80-200nM I3C). In this study, we expected DIM would suppress invasion since DIM 
is the main compound formed during I3C condensation reactions. However, we found that 
“aged” I3C, but not fresh-made one, was able to suppress DU145 cell invasion with levels of 120-
200nM (figure 2.13), the similar outcome as in the individual study with “aged” I3C (figure 2.6). 
The reason that “aged” I3C acting more potent than DIM could be that the complex of polymeric 
compounds has higher bioactivity than I3C or DIM alone. More studies need to be done to 
analyze compositions of “aged” I3C and interactions between polymeric products of I3C. 
 We also tested cell viability with fresh-made I3C using concentrations of 160 nM and 200 
nM, and found that these two levels of I3C did not decrease cell viability of DU145. However, we 
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cannot conclude if the “aged” I3C would have the same result. Therefore, more investigation 
about cell viability by treating with the “aged” I3C or DIM alone needs to be completed. 
 
Neoglucobrassicin 
 The results of the studies with hydrolyzed neoglucobrassicin (hNGB) in the Matrigel 
invasion assay suggest that hNGB did not inhibit prostate cancer cell invasion (figure 2.7). There 
are limited studies of NGB reported in the literature, but most would support lack of bioactivity 
for this form of glucosinolate. According to the Haack group (2010), hNGB did not stimulate anti-
cancer activity, such as Nrf2 translocation, glutathione peroxidase 2 (GPx2) protein expression, 
or GPx2 promoter activity in HepG2 (human liver cancer cells), indicating that hNGB did not have 
anti-cancer properties in the liver cancer cells. In addition, hNGB weakened the bioactivity of 
sulforaphane-mediated induction of the expression of NQO1 protein, GPx2 protein, and GPx2 
promoter activity in HepG2 cells (Haack et al., 2010). Liu (2014) also reported that the TRAMP 
mice fed with diet containing glucosinolates-enhanced broccoli power―with 7.6 times more 
NGB than standard broccoli―did not reduce prostate cancer development in vivo (Liu et al., 
2014, in press). Interestingly, Vo (2014) provided positive impact of NGB. They suggested that 
NGB, not hydrolyzed NGB, was able to decrease lipopolysaccharide-induced inflammation by 
reducing TNF-α expression in THP1, human monocyte cells (Vo et al., 2014).  
The different outcomes from these three previous studies may be due to different 
experimental targets. Haack’s and Liu’s studies are focused on the cancers in liver and prostate, 
respectively; while Vo focused on leukocytes. Therefore, NGB and hNGB may affect differently in 
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these two distinct experimental models with distinct mechanisms. However, more studies need 
to be done to elucidate the mechanisms of NGB and hNGB in different model systems. 
 
Quercetin 
 Quercetin (Q) is a good antioxidant that can scavenge reactive oxygen species (ROS), a 
class of reactive free radicals that may lead to carcinogenesis (Afanas’ev et al., 1989). Our study 
examined the invasion suppressive ability of Q on the human prostate cancer cell, DU145, but 
failed to find any significant decrease in invading cells over the concentration range from 1-5 µM 
(figure 2.8). 
 Previous studies suggested that 25µM and 50µM Q were capable of suppressing colony 
formation of two invasive human prostate cancer cell lines, PC-3 and DU145, but were not able 
to suppress growth of non-invasive cell line, LNCaP (Nair et al., 2004), indicating that Q may 
particularly target invasive cell lines of human prostate cancer, but at high concentrations. 
Senthilkumar and colleagues (2011) suggested that 50 and 100µM Q significantly reduced the 
invasiveness of PC-3 cells (Senthilkumar et al, 2011). They further examined the expression of 
mRNAs related to the induction of invasion in prostate cancer cells. The results show that 100 
µM Q-treated PC-3 cells were found to have lower levels of uPA, uPAR, EGF, and EGF-R, meaning 
that the invasiveness of PC-3 may have been suppressed by Q through the inhibition of uPA, 
uPAR, EGF, and EGF-R (Senthilkumar et al, 2011). 
 Our study treated DU145 cells with much lower levels of Q than others had used. Thus, it 
may not be surprising to find lack of significance effects for Q on prostate cancer cell invasion. 
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Among the studies we have reviewed, 25µM Q is the lowest effective concentration that 
inhibited colony formation of DU145 cells (Nair et al., 2004). To achieve this level in the plasma, 
4.3 grams of pure Q aglycone, or about 1.5 kg of onions containing 330 mg Q would need to be 
consumed. This also suggests that the absorption of Q from dietary sources is better than 
quercetin aglycone (reviewed in Manach et al., 2005). Although such invasion-suppressive levels 
of Q cannot be achieved by the consumption of broccoli, balanced selective plant foods 
consumed with some dietary supplements could reach the effective levels of Q by the intake of a 
wide variety of spices, fruits, and vegetables, particularly onions, where Q is present abundantly 
and can be better absorbed. Alternatively, it would be helpful to study the absorption of broccoli 
Q glycosides, mainly quercetin-3-Ο-sophoroside, in the future since these glycoside form of 
quercetin are rarely present in other plants.   
 
Future Study 
Bioactive Components 
 In this work, we focused on effects of broccoli bioactives on prostate cancer cell invasion 
in vitro using physiologically-achievable levels. Results show that SF and “aged” I3C were 
protective against DU145 prostate cancer cell invasion in the Matrigel invasion assay, and also 
indicate that invasion-suppressive concentrations of SF did not cause DU145 cell death in the 
MTT assay. However, the cytotoxicity of “aged” I3C still needs to be evaluated to determine if 
“aged” I3C would cause cell death. 
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 Since DIM is the main product of I3C condensation reactions, we compared the potency 
of “aged” I3C, fresh-made I3C, and DIM on DU145 cell invasion. The result shows that “aged” I3C 
was able to suppress DU145 cell invasion, but fresh-made I3C and DIM did not. To understand 
what polymeric products in “aged” I3C play main roles in inhibiting DU145 cell invasion, a 
detailed analysis of “aged” I3C composition needs to be done in the future. The Matrigel invasion 
assay using combinations of these polymeric products would also help us know if these 
polymeric products act synergistically or additively. 
 
RNA Expression 
 Invasion is the beginning stage of metastasis, a process of cancer dissemination from the 
primary organ to other parts of the body. Two major steps are involved in invasion: epithelial-
mesenchymal transition (EMT) of tumor cells and degradation of extracellular matrix (ECM). The 
ability of cells to accomplish invasion is highly related by specific genes. Literature has shown 
that up-regulation of N-cadherin and down-regulation of E-cadherin is related to occurrence of 
EMT (Tomita et al., 2000; Gravdal et al., 2007); while up-regulation of urokinase-like 
plasminogen (uPA) (reviewed in Hanahan & Weinberg, 2000; Arya et al., 2006) and certain kinds 
of matrix metalloproteinases (MMPs) (Page-McCaw et al., 2007; Lichtinghagen et al., 2002; Xiao 
et al., 2012) is associated with degradation of ECM. Taken together, the RNA expression of these 
proteins can be biomarkers that determine invasive ability of prostate cancer cells. Therefore, 
knowing the RNA expression profile of these proteins may be helpful to know if cells treated with 
broccoli bioactives have less invasive ability. 
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Conclusion 
 In this work, we investigated the ability of broccoli bioactive compounds to suppress 
prostate cancer cell line, DU145, invasion individually, or in selected combinations using 
physiologically-achievable levels. Among several different broccoli bioactives, 3-5µM SF and 120-
200nM “aged” I3C significantly inhibited DU145 cell invasion. Additionally, 5µM SF in 
combination with 120nM “fresh” I3C significantly inhibited invasion, but this combination was 
not significantly different from 5µM SF treatment alone, indicating that the combination of SF 
and fresh-made I3C treatment did not synergistically or additively suppress prostate cancer cell 
invasion. Other bioactive components―Q, hNGB, DIM―were also examined individually, but no 
significant impact on of DU145 cell invasion was found even treating cells beyond 
physiologically-relevant levels of Q and hNGB.  
 We also examined cell viability by the MTT assay. Results show that 3-5µM SF did not 
significantly cause cell death, indicating that SF inhibited DU145 cell invasion not by causing cell 
death, but by inhibiting invasive ability of cells.  
 Further study of the MTT assay with “aged” I3C needs to be carried out in the future. In 
addition, invasion-related RNA expression of DU145 cells treated with SF or “aged” I3C should be 
examined as well. 
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Figures and Calculation 
Figures 
 
   
   
   
   
Figure 2.1. The shaded squares on the hemocytometer were chosen for cell counting.  
 
 
 
Figure 2.2. The Matrigel invasion system is composed of a Matrigel chamber, with a layer of 
Matrigel on the porous membrane, placed in the 24-well plate with chmoattractant, which is 
able to attract cells in the chamber to invade toward the bottom of the porous membrane. 
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Figure 2.3. The ability of 100ng/mL EGF and 10% FBS to stimulate DU145 cell invasion (N=5; 
mean ± SEM). The result was analyzed by one-way ANOVA, followed by LSD test with alpha=0.05. 
Means with different letters are significantly different. 
 
 
 
Figure 2.4. Effect of incubation time on DU145 cell invasion assay (N=6; mean ± SEM). The result 
was analyzed by one-way ANOVA, followed by LSD test with alpha=0.05. Means with different 
letters are significantly different. 
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Figure 2.5. The percent invasion of DU145 cells treated with sulforaphane (N=5; mean ± SEM). 
The result was analyzed by one-way ANOVA, followed by LSD test with alpha=0.05. Means with 
different letters are significantly different. 
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Figure 2.6. The percent invasion of DU145 cells treated with “aged” indole-3-carbinol (N=5; mean 
± SEM). The result was analyzed by one-way ANOVA, followed by LSD test with alpha=0.05, 
shown in chart A; and further analyzed by linear regression analysis, shown in chart B. Means 
with different letters are significantly different. 
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Figure 2.7. The percent invasion of DU145 cells treated with neoglucobrassicin (A: N=6; B: N=5; 
mean ± SEM).  The result was analyzed by one-way ANOVA, followed by LSD test with 
alpha=0.05. Means with different letters are significantly different. 
 
 
 
Figure 2.8. The percent invasion of DU145 cells treated with quercetin (N=10; mean ± SEM). The 
assay were carried out in two separate trials with N=5 in each trial, and results were pooled and 
analyzed by one-way ANOVA, followed by LSD test with alpha=0.05. Means with different letters 
are significantly different. 
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Figure 2.9. The percent invasion of DU145 cells treated with SF or I3C or in combination (N=15; 
mean ± SEM). The assay were carried out in three separate trials with N=5 in each trial, and 
results were pooled and analyzed by one-way ANOVA, followed by LSD test with alpha=0.05. 
Means with different letters are significantly different. 
 
 
 
Figure 2.10. The percent invasion of DU145 cells treated with SF or I3C or in combination (N=5; 
mean ± SEM). The result was analyzed by one-way ANOVA, followed by LSD test with alpha=0.05. 
Means with different letters are significantly different. 
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Figure 2.11. The cell viability of DU145 cells treated with sulforaphane (treatment: N=3, DMSO: 
N=6; mean ± SEM). The result was analyzed by one-way ANOVA, followed by LSD test with 
alpha=0.05. Significant differences are indicated by “*”. 
 
 
 
 
Figure 2.12. The cell viability of DU145 cells treated with indole-3-carbinol (treatment: N=3, 
DMSO: N=6; mean ± SEM). The result was analyzed by one-way ANOVA, followed by LSD test 
with alpha=0.05. Significant differences are indicated by “*”. 
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Figure 2.13. The percent invasion of DU145 cells treated with “aged” I3C, fresh-made I3C, and 
DIM (DMSO: N=5, treatments: N=3; mean ± SEM). The result was analyzed by one-way ANOVA, 
followed by LSD test with alpha=0.05. Significant differences are indicated by “*”. 
 
Calculation 
 
Calculation 2.1. The calculation for cell number using a hemocytometer. 
1. Number of cells from chamber 1+ number of cells from chamber 2 = X 
2. 
𝑋
10
= 𝑡ℎ𝑒 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠/𝑠𝑞𝑢𝑎𝑟𝑒 (𝑄) 
3. 𝑄 × 10 (𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟) × 104 = 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠/𝑚𝐿 𝑖𝑛 𝑡ℎ𝑒 𝑚𝑒𝑑𝑖𝑢𝑚  
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